Keyphrases
Randomized Controlled Trial
100%
Emphysema
100%
Selective Agonist
100%
Retinoic Acid Receptor
100%
Palovarotene
100%
Placebo
37%
Lung Density
37%
Retinoids
25%
Alpha-1 Antitrypsin Deficiency
25%
Computed Tomography
12%
Placebo-controlled
12%
Patient-completed
12%
Severe Emphysema
12%
Lung
12%
Inflammation
12%
Functional Improvement
12%
Volume Change
12%
Baseline Characteristics
12%
Moderate to Severe
12%
Treatment Difference
12%
Investigator-initiated
12%
International Registry
12%
Significant Benefit
12%
Alpha-1 Antitrypsin
12%
Functional Parameters
12%
Pharmacological Effects
12%
Structural Repair
12%
Percentile Values
12%
Respiratory Stimulant
12%
INIS
receptors
100%
emphysema
100%
retinoic acid
100%
lungs
80%
patients
80%
density
60%
repair
40%
volume
20%
drugs
20%
safety
20%
computed tomography
20%
animals
20%
populations
20%
inflammation
20%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Emphysema
100%
Retinoic Acid Receptor
100%
Palovarotene
100%
Placebo
50%
Retinoid
25%
Alpha 1 Antitrypsin Deficiency
25%
Inflammation
12%
Alpha 1 Antitrypsin
12%